HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenjing Wang Selected Research

methyl acetate

2/2015{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).
1/2015{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3.
3/2011{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM): its anti-cancer efficacy and intercalation mechanism identified via multi-model systems.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenjing Wang Research Topics

Disease

80Neoplasms (Cancer)
11/2022 - 10/2008
13Infections
01/2021 - 05/2011
12Neoplasm Metastasis (Metastasis)
06/2022 - 02/2017
11Hepatocellular Carcinoma (Hepatoma)
11/2022 - 01/2009
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2008
9Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2015
9Breast Neoplasms (Breast Cancer)
10/2021 - 12/2011
8Inflammation (Inflammations)
11/2021 - 08/2015
7Lung Neoplasms (Lung Cancer)
01/2022 - 10/2008
6COVID-19
11/2022 - 01/2020
6Hypoxia (Hypoxemia)
02/2022 - 09/2016
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 10/2008
5Pathologic Processes
05/2022 - 04/2020
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2017
5Hemorrhage
01/2022 - 09/2011
5Leukemia
01/2019 - 02/2002
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 01/2016
4Adenocarcinoma of Lung
01/2021 - 11/2019
4Brucellosis (Malta Fever)
01/2020 - 03/2015
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2019 - 01/2017
4Body Weight (Weight, Body)
07/2018 - 01/2002
4Embryo Loss
03/2011 - 06/2009
3Neuroinflammatory Diseases
05/2022 - 05/2020
3Myocardial Infarction
02/2022 - 12/2018
3Male Infertility (Male Sterility)
01/2022 - 05/2014
3Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 02/2019
3Virus Diseases (Viral Diseases)
11/2021 - 01/2012
3Squamous Cell Carcinoma of Head and Neck
11/2021 - 01/2020
3Chronic Obstructive Pulmonary Disease (COPD)
04/2021 - 01/2017
3Ovarian Epithelial Carcinoma
04/2021 - 08/2019
3Atherosclerosis
03/2021 - 03/2014
3Acute Kidney Injury (Acute Renal Failure)
01/2021 - 08/2018
3Type 2 Diabetes Mellitus (MODY)
07/2020 - 01/2018
3Carcinogenesis
01/2020 - 05/2017
3Acute Promyelocytic Leukemia
04/2019 - 10/2017
3Hyperglycemia
01/2019 - 01/2002
3Cysts
01/2013 - 11/2005
2Alzheimer Disease (Alzheimer's Disease)
06/2022 - 01/2021
2Carcinoma (Carcinomatosis)
03/2022 - 01/2021
2Cicatrix (Scar)
03/2022 - 04/2017

Drug/Important Bio-Agent (IBA)

25Biomarkers (Surrogate Marker)IBA
06/2022 - 10/2008
21Proteins (Proteins, Gene)FDA Link
11/2022 - 11/2005
11Pharmaceutical PreparationsIBA
05/2022 - 02/2017
8Long Noncoding RNAIBA
01/2022 - 01/2019
7DNA (Deoxyribonucleic Acid)IBA
05/2022 - 05/2011
7CytokinesIBA
01/2022 - 01/2018
7Glucose (Dextrose)FDA LinkGeneric
07/2020 - 01/2002
6RNA (Ribonucleic Acid)IBA
11/2022 - 02/2009
6Messenger RNA (mRNA)IBA
01/2022 - 11/2005
6MicroRNAs (MicroRNA)IBA
01/2021 - 10/2008
5Blood Glucose (Blood Sugar)IBA
02/2022 - 01/2002
5Biological ProductsIBA
01/2022 - 01/2017
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 10/2009
5Cisplatin (Platino)FDA LinkGeneric
01/2020 - 11/2015
4ErbB Receptors (EGF Receptor)IBA
10/2022 - 11/2019
4AntigensIBA
01/2022 - 06/2018
4LipidsIBA
01/2022 - 08/2019
4Antiviral Agents (Antivirals)IBA
11/2021 - 01/2013
4Interleukin-6 (Interleukin 6)IBA
11/2021 - 01/2018
4Interleukin-10 (Interleukin 10)IBA
01/2021 - 01/2018
4AcidsIBA
01/2021 - 09/2010
4Circular RNAIBA
01/2021 - 01/2020
4ArsenicIBA
04/2019 - 10/2017
3Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 01/2016
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2022 - 01/2021
3IntegrinsIBA
07/2022 - 08/2019
3Viral RNAIBA
05/2022 - 01/2020
3Polysaccharides (Glycans)IBA
01/2022 - 02/2017
3InterferonsIBA
11/2021 - 01/2012
33,3'-diindolylmethane (diindolylmethane)IBA
10/2021 - 01/2015
3AdiponectinIBA
06/2021 - 09/2016
3Sirtuin 3IBA
03/2021 - 01/2015
3SaltsIBA
01/2021 - 01/2018
3human ERBB2 proteinIBA
01/2021 - 11/2019
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2019
3LigandsIBA
01/2021 - 01/2020
3AntibodiesIBA
01/2020 - 01/2013
3Peptides (Polypeptides)IBA
01/2020 - 01/2013
3Arsenic Trioxide (Trisenox)FDA Link
04/2019 - 10/2017
3AlbuminsIBA
01/2019 - 01/2018
3GoldIBA
12/2018 - 01/2012
3Telomerase (Telomerase Reverse Transcriptase)IBA
07/2018 - 03/2016
3astragaloside AIBA
07/2018 - 01/2016
3Matrix Metalloproteinases (MMPs)IBA
01/2018 - 12/2011
3methyl acetateIBA
02/2015 - 03/2011
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2022 - 01/2021
2Amyloid beta-PeptidesIBA
06/2022 - 01/2021
2Antidepressive Agents (Antidepressants)IBA
05/2022 - 11/2021

Therapy/Procedure

29Therapeutics
01/2022 - 02/2009
9Drug Therapy (Chemotherapy)
01/2022 - 01/2016
6Immunotherapy
01/2022 - 06/2018
5Liver Transplantation
10/2021 - 10/2014
5Transplantation
04/2020 - 01/2002
4Photothermal Therapy
01/2021 - 06/2018
4Lasers (Laser)
06/2018 - 01/2009
3Cesarean Section (Caesarean Section)
03/2022 - 06/2014
3Aftercare (After-Treatment)
01/2022 - 06/2014
3Precision Medicine
09/2021 - 06/2017
3Radiotherapy
01/2021 - 01/2015
3Continuous Renal Replacement Therapy
12/2019 - 08/2018